Literature DB >> 6385257

The use of intraperitoneal chemotherapy in the treatment of ovarian cancer.

C Myers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385257

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

Review 1.  Regulation of natural killer activity.

Authors:  J R Ortaldo
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

3.  Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.

Authors:  A Sharma; N L Straubinger; R M Straubinger
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

4.  Effect of tolmetin sodium dihydrate on adhesion formation by intraperitoneal administration of antineoplastic agents.

Authors:  K E Rodgers; W Girgis; G S diZerega
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Pharmacokinetics of carboplatin after intraperitoneal administration.

Authors:  F Elferink; W J van der Vijgh; I Klein; W W ten Bokkel Huinink; R Dubbelman; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  Preclinical evaluation of aclacinomycin A for the intraperitoneal treatment of human ovarian carcinoma.

Authors:  K G Louie; T C Hamilton; B C Behrens; K R Grotzinger; W M McKoy; C E Myers; R C Young; R F Ozols
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 7.  Clinical pharmacology of 5-fluorouracil.

Authors:  R B Diasio; B E Harris
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.